AAAAAA
Results: 1-25/105
Authors:
GEISLER J
KING N
ANKER G
ORNATI G
DISALLE E
LONNING PE
DOWSETT M
Citation: J. Geisler et al., IN-VIVO INHIBITION OF AROMATIZATION BY EXEMESTANE, A NOVEL IRREVERSIBLE AROMATASE INHIBITOR, IN POSTMENOPAUSAL BREAST-CANCER PATIENTS, Clinical cancer research, 4(9), 1998, pp. 2089-2093
Authors:
JOHNSTON SRD
DOWSETT M
RIDDLER S
JARMAN M
Citation: Srd. Johnston et al., IDOXIFENE ANTAGONISM OF ESTRADIOL-DEPENDENT MCF-7 BREAST-CANCER XENOGRAFT GROWTH, European journal of cancer, 34, 1998, pp. 378-378
Authors:
DOWSETT M
YATES R
WONG YWJ
Citation: M. Dowsett et al., ARIMIDEX (ANASTROZOLE) - LACK OF INTERACTIONS WITH TAMOXIFEN, ANTIPYRINE, CIMETIDINE AND WARFARIN, European journal of cancer, 34, 1998, pp. 100-100
Authors:
GREGORY RK
ELLIS PA
POWLES TJ
DOWSETT M
Citation: Rk. Gregory et al., APOPTOTIC INDEX (AL) AND KI67 AS PROGNOSTIC FACTORS IN A TRIAL OF PRIMARY MEDICAL THERAPY (PMT) FOR PRIMARY-CARCINOMA OF THE BREAST, Annals of oncology, 9, 1998, pp. 23-23
Authors:
DOWSETT M
Citation: M. Dowsett, HORMONAL RECEPTORS IN BREAST-CANCER, Annals of oncology, 9, 1998, pp. 23-23
Authors:
DOWSETT M
DETRE S
ORMEROD MG
ELLIS PA
MAINWARING PN
TITLEY JC
SMITH IE
Citation: M. Dowsett et al., ANALYSIS AND SORTING OF APOPTOTIC CELLS FROM FINE-NEEDLE ASPIRATES OFEXCISED HUMAN PRIMARY BREAST CARCINOMAS, Cytometry, 32(4), 1998, pp. 291-300
Authors:
DOWSETT M
Citation: M. Dowsett, THEORETICAL CONSIDERATIONS FOR THE IDEAL AROMATASE INHIBITOR, Breast cancer research and treatment, 49, 1998, pp. 39-44
Authors:
LONNING PE
GEISLER J
DOWSETT M
Citation: Pe. Lonning et al., PHARMACOLOGICAL AND CLINICAL PROFILE OF ANASTROZOLE, Breast cancer research and treatment, 49, 1998, pp. 53-57
Authors:
BHATNAGAR A
DOWSETT M
SANTEN D
SMITH I
BOEHM R
LONNING P
TEDESCHI M
LASSUS M
MILLER B
TOMINAGA T
Citation: A. Bhatnagar et al., PHARMACOLOGICAL PROFILE OF AN IDEAL AROMATASE INHIBITOR IN THE TREATMENT OF BREAST-CANCER - DISCUSSION OF SESSION 2, Breast cancer research and treatment, 49, 1998, pp. 73-77
Authors:
SHENTON KC
DOWSETT M
LU Q
BRODIE A
SASANO H
SACKS NPM
ROWLANDS MG
Citation: Kc. Shenton et al., COMPARISON OF BIOCHEMICAL AROMATASE-ACTIVITY WITH AROMATASE IMMUNOHISTOCHEMISTRY IN HUMAN BREAST CARCINOMAS, Breast cancer research and treatment, 49, 1998, pp. 101-107
Authors:
ELLIS PA
SMITH IE
DETRE S
BURTON SA
SALTER J
AHERN R
WALSH G
JOHNSTON SRD
DOWSETT M
Citation: Pa. Ellis et al., REDUCED APOPTOSIS AND PROLIFERATION AND INCREASED BCL-2 IN RESIDUAL BREAST-CANCER FOLLOWING PREOPERATIVE CHEMOTHERAPY, Breast cancer research and treatment, 48(2), 1998, pp. 107-116
Authors:
MAKRIS A
POWLES TJ
ALLRED DC
ASHLEY S
ORMEROD MG
TITLEY JC
DOWSETT M
Citation: A. Makris et al., CHANGES IN HORMONE RECEPTORS AND PROLIFERATION MARKERS IN TAMOXIFEN TREATED BREAST-CANCER PATIENTS AND THE RELATIONSHIP WITH RESPONSE, Breast cancer research and treatment, 48(1), 1998, pp. 11-20
Authors:
POWLES T
EELES R
ASHLEY S
EASTON D
CHANG J
DOWSETT M
TIDY A
VIGGERS J
DAVEY J
Citation: T. Powles et al., INTERIM ANALYSIS OF THE INCIDENCE OF BREAST-CANCER IN THE ROYAL-MARSDEN-HOSPITAL TAMOXIFEN RANDOMIZED CHEMOPREVENTION TRIAL, Lancet, 352(9122), 1998, pp. 98-101
Authors:
DOWSETT M
Citation: M. Dowsett, IMPROVED PROGNOSIS FOR BIOMARKERS IN BREAST-CANCER, Lancet, 351(9118), 1998, pp. 1753-1754
Authors:
MAINWARING PN
ELLIS PA
DETRE S
SMITH IE
DOWSETT M
Citation: Pn. Mainwaring et al., COMPARISON OF IN-SITU METHODS TO ASSESS DNA CLEAVAGE IN APOPTOTIC CELLS IN PATIENTS WITH BREAST-CANCER, Journal of Clinical Pathology, 51(1), 1998, pp. 34-37
Authors:
GREGORY R
ELLIS P
POWLES T
DOWSETT M
Citation: R. Gregory et al., APOPTOTIC INDEX AS A PROGNOSTIC FACTOR IN A TRIAL OF PRIMARY MEDICAL THERAPY FOR CARCINOMA OF THE BREAST, British Journal of Cancer, 78, 1998, pp. 28-28
Authors:
ARCHER CD
ASHLEY S
DOWSETT M
SMITH IE
Citation: Cd. Archer et al., BIOMARKERS FOR THE PREDICTION OF COMPLETE CLINICAL-RESPONSE TO PRIMARY CHEMOTHERAPY IN EARLY BREAST-CANCER, British Journal of Cancer, 78, 1998, pp. 44-44
REVERSAL OF RELATION BETWEEN BODY-MASS AND ENDOGENOUS ESTROGEN CONCENTRATIONS WITH MENOPAUSAL STATUS
Authors:
THOMAS HV
KEY TJ
ALLEN DS
MOORE JW
DOWSETT M
FENTIMAN IS
WANG DY
Citation: Hv. Thomas et al., REVERSAL OF RELATION BETWEEN BODY-MASS AND ENDOGENOUS ESTROGEN CONCENTRATIONS WITH MENOPAUSAL STATUS, Journal of the National Cancer Institute, 89(5), 1997, pp. 396-397
Authors:
DOWSETT M
Citation: M. Dowsett, AROMATASE INHIBITORS - CURRENT STATUS AND FUTURE APPLICATIONS, Endocrine-related cancer, 4(3), 1997, pp. 313-321
Authors:
NEWBY JC
JOHNSTON SRD
SMITH IE
DOWSETT M
Citation: Jc. Newby et al., EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND C-ERBB2 DURING THEDEVELOPMENT OF TAMOXIFEN RESISTANCE IN HUMAN BREAST-CANCER, Clinical cancer research, 3(9), 1997, pp. 1643-1651
Authors:
MAKRIS A
POWLES TJ
DOWSETT M
OSBORNE CK
TROTT PA
FERNANDO IN
ASHLEY SE
ORMEROD MG
TITLEY JC
GREGORY RK
ALLRED DC
Citation: A. Makris et al., PREDICTION OF RESPONSE TO NEOADJUVANT CHEMOENDOCRINE THERAPY IN PRIMARY BREAST CARCINOMAS, Clinical cancer research, 3(4), 1997, pp. 593-600
Authors:
ANDERSEN TI
WOOSTER R
LAAKE K
COLLINS N
WARREN W
SKREDE M
EELES R
TVEIT KM
JOHNSTON SRD
DOWSETT M
OLSEN AO
MOLLER P
STRATTON MR
BORRESENDALE AL
Citation: Ti. Andersen et al., SCREENING FOR ESR MUTATIONS IN BREAST AND OVARIAN-CANCER PATIENTS, Human mutation, 9(6), 1997, pp. 531-536
Authors:
CHAN CMW
DOWSETT M
Citation: Cmw. Chan et M. Dowsett, A NOVEL ESTROGEN-RECEPTOR VARIANT MESSENGER-RNA LACKING EXON-4 TO EXON-6 IN BREAST-CARCINOMA, Journal of steroid biochemistry and molecular biology, 62(5-6), 1997, pp. 419-430
Authors:
DOWSETT M
Citation: M. Dowsett, FUTURE USES FOR AROMATASE INHIBITORS IN BREAST-CANCER, Journal of steroid biochemistry and molecular biology, 61(3-6), 1997, pp. 261-266
Authors:
BARRIE SE
HAYNES BP
POTTER GA
CHAN FCY
GODDARD PM
DOWSETT M
JARMAN M
Citation: Se. Barrie et al., BIOCHEMISTRY AND PHARMACOKINETICS OF POTENT NONSTEROIDAL CYTOCHROME P450(17-ALPHA) INHIBITORS, Journal of steroid biochemistry and molecular biology, 60(5-6), 1997, pp. 347-351